Radiotherapy dates back more than a hundred years, yet it still remains a core part of cancer treatment today. The problem with this form of treatment is that it is not targeted and, as a result, there are a number of short- and long-term side effects which can impact patients’ lives. This is why the recent surge in development for radiopharmaceuticals is drawing attention.
Radiopharmaceutical treatments retain the advantages of radiotherapy’s ability to kill cancer cells, but are able to deliver the therapy in a more targeted manner. In addition, radiopharmaceuticals can also be used in diagnostic imaging for the detection of cancer cells.
